Home > SANTE - SCIENCES DE LA VIE > Industrie Pharmaceutique > Indevus Pharmaceuticals: ...
AUTRES RESSOURCES
 
AUTRES SECTEURS
 
TOUS NOS SECTEURS
 
Industrie Pharmaceutique > Etude de marché sectorielle
 Indevus Pharmaceuticals: Premium Company Profile
€ 396,00
Editeur :
Datamonitor
Langue :
Anglais
Date de publication :
Décembre 2007
Taille du document :
58
Autres informations :
Description , Table des matières
 

Recevez cette publication aujourd'hui !
Plus d'information ?
+33 437 37 1637
 
Documents Publics
1,200,000 documents
Téléchargement illimités
 
Etudes Privées
50,000 rapports et études
Paiement à la piéce
 
1.Télécharger nos rapports publics

Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...

Nos documents publics sur le même théme (5)
Pharmaceutical industry market in USA
86 pages | Août 2005 | Anglais
 
 
   
Main focus: pharmaceuticals,pharmaceutical,pharmacovigilance
Research focus: industry structure,market size and estimates,
Geographic focus: usa,united kingdom,india,germany,thailand,nigeria,...
   
Social protection market in Australia
127 pages | Mai 2003 | Anglais
 
 
   
Main focus: health expenditure,health insurance,...,hospitals,...
Research focus: market segmentation,demand analysis,market outlook,
Geographic focus: australia,japan,usa,new zealand,france,canada,...
   
Pharmaceutical industry market in USA and France
64 pages | Mars 2005 | Anglais
 
 
   
Main focus: pharmaceuticals,atherosclerosis,hypertension
Research focus: market size and estimates,market outlook,
Geographic focus: usa,france,canada
   
Pharmaceutical industry market in USA and France
64 pages | Novembre 2005 | Anglais
 
 
   
Main focus: pharmaceuticals,dyslipidemia,pharmaceutical,...,...
Research focus: market size and estimates,market outlook,
Geographic focus: usa,france,canada,poland
   
Pharmaceutical industry market in India
70 pages | Septembre 2006 | Anglais
 
 
   
Main focus: pharmaceuticals,pharmaceutical,...
Research focus: market size and estimates,industry structure,
Geographic focus: india,usa,china,france,united kingdom,malaysia,...
   
Autres recherches sur le même thème
Rechercher d'autres rapports publics à télécharger
 
 
 
2. Rechercher d'autres rapports et études à commander

Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux


Rapports privés en relation
Chinese Markets for Pharmaceuticals
225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic
3 500,00 €
 
 
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis
188 pages | Septembre 2001 |
Global Parallel Trade Outlook 2001: A country-by-country analysis, a new report by Reuters Business Insight, provides a detailed update on the status of parallel trade in the global marketplace.
1 200,00 €
 
 
Antisense Therapy: Technical Aspects and Commercial Opportunities
334 pages | Mars 2000 |
Antisense therapy interferes with the expression of disease-causing proteins, thus offering a direct and selective intervention in the disease process.
Besides the well known oligonucleotides (
955,00 €
 
 
Bridging the Pharmaceutical Earnings gap: Key Strategies in the race for growth
173 pages | Mars 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once near unrestricted revenue expansion existed, external pressures now act in unison
955,00 €
 
 
Regulatory Affairs: Paths to Approval
113 pages | Février 1999 |
Area Specific Chapters : The regulatory systems governing clinical trials and drug approvals are examined for the US, Europe, and Australia, Canada and Japan, including analysis of the implicatio
795,00 €
 
 
Patient Power in the Pharmaceutical Industry: The shift towards more informed, more powerful consumers of drugs
119 pages | Juin 1999 |
The dramatic rise in patient power in recent years presents a new and challenging opportunity to pharmaceutical companies, healthcare providers and governments alike.
A great need exists for ph
795,00 €
 
 
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru
955,00 €
 
 
Pfizer's Recent Takeover
15 pages | Juillet 2002 |
On 15th July 2002, Pfizer announced the acquisition of Pharmacia in a stock-for-stock transaction valued at $60 billion, expanding the company's core strengths in pharmaceuticals and health care.
300,00 €
 
 
Top Ten and Emerging Pharmaceutical markets
214 pages | Juillet 1999 |
Introduction : Provides the background to the report by identifying the major trends within global healthcare markets and how these interact and influence the markets for pharmaceuticals.
Mar
795,00 €
 
 
The Pharmaceutical Mergers and Acquisitions Outlook 2001
128 pages | Octobre 2001 |
Pharmaceutical companies have recently undertaken extensive M&A activity to either build critical mass, create organic growth or through strategic alliances to build virtual mass.
The Pharmaceu
1 200,00 €
 
 
 
Autres secteurs en relation
Rechercher d'autres rapports!
 
 
 
Présentation de l'étude de marché - Description & Table des matières
 Indevus Pharmaceuticals: Premium Company Profile

Introduction

Indevus Pharmaceuticals is a biopharmaceutical company focused on obtaining product candidates and product from other pharmaceutical and biotechnology companies through collaboration, in licensing and acquisitions. The company's acquisition of Valera Pharmaceuticals in April 2007 has expanded its product portfolio, establishing it as an emerging leader in the areas of urology and men's health.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    Indevus Pharmaceuticals is a biopharmaceutical company engaged in the acquisition, development and commercialization of products to treat urological, gynecological and men's health conditions.

    The company's marketed products are: Sanctura for the treatment of overactive bladder; Delatestryl for treating hypogonadism in men; Supprelin-LA for the treatment of central precocious puberty; and Vantas indicated in hormone suppression therapy for advanced prostate cancer.

    Indevus Pharmaceuticals derives its revenues from contract and license fees and product revenues which include revenues from sales of products, commissions and royalties. The company obtains products and product candidates through acquisitions and licensing agreements with other pharmaceutical and biotechnology companies.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization


  •  

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 7
    Company Overview and Key Facts 7
    Business Description 8
    History 9
    Locations and Subsidiaries 13
    Company Financials 14
    Stock Market Performance 14
    P&L 16
    Balance Sheet 19
    Cash Flow 19
    Business Segment Performance 20
    Products & Services 22
    Marketed Products 22
    Pipeline Products 24
    AC Forecast Product Sales 27
    Competitors and Strategic Business Relationships 30
    Key Competitors 30
    Key Suppliers 31
    Key Clients 32
    Shareholding Structure 34
    Strategy 35
    Company View 35
    Corporate Strategy 37
    SWOT Analysis 39
    Overview 39
    Strengths 40
    Weaknesses 41
    Opportunities 42
    Threats 44
    Value Chain Analysis 45
    Overview 45
    Discovery and Product Development 45
    Manufacturing 46
    Sales 46
    Scorecard 47
    Overview 47
    Scorecard Analysis 48
    Key Employees 49
    List of Key Employees 49
    Key Employee Biographies 50
    Financial and Operational Overview 55
    Financial and Operational Overview 55
    APPENDIX 58
    Ask the analyst 58
    Datamonitor consulting 58
    Disclaimer 58


    TABLE OF FIGURES
    Figure 1: Indevus- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 17
    Figure 2: Indevus- Key Strategic Revenues, 2002-2006 ($ Mn) 21
    Figure 3: Indevus- Key Strategic Revenues, 2006-2010 ($ Mn) 29


    TABLE OF TABLES
    Table 1: Indevus- Key Facts 7
    Table 2: Indevus– Locations and Subsidiaries 13
    Table 3: Indevus - Year-End Share Price and Market Capitalization, 2002-2006 ($) 14
    Table 4: Indevus- Key Events Impacting Share Price Performance 15
    Table 5: Indevus- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 16
    Table 6: Indevus- Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 18
    Table 7: Indevus – Balance Sheet, 2002-2006 ($ Mn) 19
    Table 8: Indevus - Cash Flow, 2002-2006 ($ Mn) 19
    Table 9: Indevus- Revenue Breakdown, 2002-2006 ($ Mn) 20
    Table 10: Indevus- Marketed Products 22
    Table 11: Indevus- In-house Pipeline Products 24
    Table 12: Indevus- Collaboration Products 26
    Table 13: Indevus- Forecast Sales, 2006-2010 ($ Mn) 27
    Table 14: Indevus- Key Competitors 31
    Table 15: Indevus- Key Suppliers 32
    Table 16: Indevus- Key Clients 33
    Table 17: Indevus- Key Shareholders 34
    Table 18: Indevus- SWOT Analysis Summary 39
    Table 19: Indevus- Value Chain Analysis 45
    Table 20: Indevus- Scorecard 47
    Table 21: Indevus- Key Employees 49
    Table 22: Indevus – Financial and Operational Overview 56



    New Search:

    PPLSEN